Integra LifeSciences Holdings CorporationIARTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, slight contraction.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$24.96M
↓ 78% below average
Average (9y)
$113.98M
Historical baseline
Range
High:$264.35M
Low:$24.96M
CAGR
-9.5%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $24.96M | -65.8% |
| 2023 | $73.09M | -66.4% |
| 2022 | $217.38M | -17.8% |
| 2021 | $264.35M | +88.9% |
| 2020 | $139.94M | +44.4% |
| 2019 | $96.90M | -20.5% |
| 2018 | $121.94M | +71.7% |
| 2017 | $71.04M | +2.8% |
| 2016 | $69.08M | +13.1% |
| 2015 | $61.07M | - |